MDT

100.01

+0.25%↑

146.96

+0.77%↑

VEEV

244.4

+2.32%↑

HQY

97.41

-0.3%↓

PHR.US

16.95

-3.09%↓

MDT

100.01

+0.25%↑

146.96

+0.77%↑

VEEV

244.4

+2.32%↑

HQY

97.41

-0.3%↓

PHR.US

16.95

-3.09%↓

MDT

100.01

+0.25%↑

146.96

+0.77%↑

VEEV

244.4

+2.32%↑

HQY

97.41

-0.3%↓

PHR.US

16.95

-3.09%↓

MDT

100.01

+0.25%↑

146.96

+0.77%↑

VEEV

244.4

+2.32%↑

HQY

97.41

-0.3%↓

PHR.US

16.95

-3.09%↓

MDT

100.01

+0.25%↑

146.96

+0.77%↑

VEEV

244.4

+2.32%↑

HQY

97.41

-0.3%↓

PHR.US

16.95

-3.09%↓

Kodu・Aktsiate loetelu・Embecta Corp

Embecta Corp

Suletud

SektorTervishoid

12.48 1.3

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

12.14

Max

12.61

Põhinäitajad
By Trading Economics
Sissetulek	-19M 26M
Müük	-32M 264M
P/E Sektori keskmine	7.173 87.826
Dividenditootlus	5.15
Kasumimarginaal	10
Töötajad	1,850
EBITDA	-40M 71M

Dividendid
By Dow Jones
Dividenditootlus Sektori keskmine	5.15% 2.26%
Järgmine tulemuste avaldamine	5. veebr 2026

Turustatistika
By TradingEconomics
Turukapital	-106M 688M
Eelmine avamishind	11.18
Eelmine sulgemishind	12.48

Uudiste sentiment

By Acuity

20%

80%

38 / 372 Pingereas Healthcare

Embecta Corp Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

7. jaan 2026, 23:11 UTC

Tulu

Samsung Electronics Expects Record Fourth-Quarter Profit Beat

7. jaan 2026, 22:55 UTC

Suurimad hinnamuutused turgudel

Defense Stocks Rebound After Trump Says He Wants $1.5 Trillion Military Budget in 2027

7. jaan 2026, 21:39 UTC

Suurimad hinnamuutused turgudel

Raytheon Down Following Trump Post Criticizing Company

7. jaan 2026, 20:13 UTC

Suurimad hinnamuutused turgudel

AbbVie, Revolution Medicines Stocks Gain on Report of Possible Acquisition

7. jaan 2026, 20:03 UTC

Suurimad hinnamuutused turgudel

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Executive Pay

7. jaan 2026, 23:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

7. jaan 2026, 23:46 UTC

Market Talk

Nikkei May Decline as China-Japan Tensions Linger -- Market Talk

7. jaan 2026, 23:42 UTC

Omandamised, ülevõtmised, äriostud

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 5th Update

7. jaan 2026, 23:34 UTC

Market Talk

Gold Edges Higher Amid Lingering Geopolitical Risks -- Market Talk

7. jaan 2026, 23:29 UTC

Omandamised, ülevõtmised, äriostud

Constellation Closes Deal for Calpine, Creating Biggest Electricity Generator -- Barrons.com

7. jaan 2026, 22:48 UTC

Market Talk

Infratil's Discount to Net Asset Value Too Good to Ignore -- Market Talk

7. jaan 2026, 22:46 UTC

Tulu

Samsung Electronics Estimates 2025 Rev KRW332.770T Vs KRW300.870T >005930.SE

7. jaan 2026, 22:45 UTC

Tulu

Samsung Electronics Estimates 2025 Oper Pft KRW43.530T Vs KRW32.730T >005930.SE

7. jaan 2026, 22:43 UTC

Omandamised, ülevõtmised, äriostud

Revolution Medicines Draws Takeover Interest -- 2nd Update

7. jaan 2026, 22:42 UTC

Tulu

Samsung Electronics 4Q Oper Pft Estimate Beat FactSet-Compiled Consensus Forecast

7. jaan 2026, 22:41 UTC

Tulu

Samsung Electronics Sees 4Q Oper Pft KRW20.000T Vs KRW6.490T >005930.SE

7. jaan 2026, 22:41 UTC

Tulu

Samsung Electronics Sees 4Q Rev KRW93.000T Vs KRW75.790T >005930.SE

7. jaan 2026, 22:40 UTC

Suurimad hinnamuutused turgudel

Defense Stocks Rebound After Trump Says He Wants $1.5T Military Budget in 2027

7. jaan 2026, 22:31 UTC

Market Talk

Macro Tailwinds Strengthen for Chalice Mining -- Market Talk

7. jaan 2026, 22:22 UTC

Market Talk

Northern Star's Run of Disruptions Increasingly a Concern -- Market Talk

7. jaan 2026, 22:01 UTC

Market Talk

Valuations of New Zealand Property Stocks Supportive -- Market Talk

7. jaan 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

7. jaan 2026, 21:46 UTC

Market Talk

Northern Star's Revised Guidance Looks Achievable -- Market Talk

7. jaan 2026, 21:22 UTC

Omandamised, ülevõtmised, äriostud

Eli Lilly to Buy Ventyx Biosciences for $14 a Share >LLY VTYX

7. jaan 2026, 21:18 UTC

Omandamised, ülevõtmised, äriostud

Lilly To Acquire Ventyx Biosciences To Advance Oral Therapies Targeting Inflammatory-mediated Diseases >LLY VTYX

7. jaan 2026, 21:05 UTC

Omandamised, ülevõtmised, äriostud

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 4th Update

7. jaan 2026, 20:29 UTC

Omandamised, ülevõtmised, äriostud

AbbVie Near Deal for Revolution Medicines -- Update

7. jaan 2026, 20:27 UTC

Market Talk

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

7. jaan 2026, 19:58 UTC

Market Talk

Oil Falls As U.S. to Receive Sanctioned Venezuelan Crude -- Market Talk

7. jaan 2026, 19:48 UTC

Suurimad hinnamuutused turgudel

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Exec Pay

Võrdlus sarnastega

Hinnamuutus

Embecta Corp Prognoos

Hinnangu Konsensus

By TipRanks

Neutraalne

1 ratings

Osta

Hoia

Müü

Põhineb 1 analüütiku instrumendi Embecta Corp aktsia reitingul - viimase 3 kuu andmed.

Sentiment

By Acuity

38 / 372 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Embecta Corp

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.